Editorial Commentary
Beyond survival: the role of quality of life in modern urothelial cancer therapy
Translational Cancer Research
2025;
14
(9)
:5178-5180
.
(30 September 2025)
Original Article
B3GNT3 is an oncogenic and prognostic biomarker in human tumors via pan-cancer analysis combined with experimental validation
Translational Cancer Research
2025;
14
(9)
:5181-5198
.
(30 September 2025)
Combination of Danggui Buxue Tang and concurrent chemoradiotherapy improves treatment outcomes by strengthening B cell immunity in patients with nasopharyngeal carcinoma—a double-blind, randomized trial
Translational Cancer Research
2025;
14
(9)
:5199-5210
.
(30 September 2025)
Development and validation of a gene signature for gastric cancer prognosis based on propionate metabolism
Translational Cancer Research
2025;
14
(9)
:5211-5225
.
(30 September 2025)
Development and validation of a necroptosis-related gene signature for predicting prognosis and immune infiltration in papillary thyroid cancer
Translational Cancer Research
2025;
14
(9)
:5226-5244
.
(30 September 2025)
A nomogram for predicting overall survival in advanced hepatocellular carcinoma patients receiving radiotherapy combined with targeted therapy: a multicenter retrospective study
Translational Cancer Research
2025;
14
(9)
:5245-5254
.
(30 September 2025)
Efficacy and safety of antibody-drug conjugates in the treatment of non-small cell lung cancer: a systematic review and meta-analysis of prospective clinical trials
Translational Cancer Research
2025;
14
(9)
:5255-5270
.
(30 September 2025)
KCNJ11 as a prognostic and therapeutic target in colon adenocarcinoma
Translational Cancer Research
2025;
14
(9)
:5271-5280
.
(30 September 2025)
Establishment of a prognostic model and immune profiling based on phagocytic regulatory genes in hepatocellular carcinoma
Translational Cancer Research
2025;
14
(9)
:5281-5296
.
(30 September 2025)
Neochlorogenic acid inhibits gastric cancer cell growth through apoptosis and cell cycle arrest
Translational Cancer Research
2025;
14
(9)
:5297-5310
.
(30 September 2025)
Prognostic and predictive roles of circulating microRNAs as biomarkers in head and neck cancer patients in the Northern Territory, Australia undergoing chemoradiotherapy—a pilot prospective cohort study
Translational Cancer Research
2025;
14
(9)
:5311-5323
.
(30 September 2025)
Prognostic signature based on hypoxia and RNA methylation regulatory genes can improve the prognostic and recurrence prediction ability of low-grade glioma
Translational Cancer Research
2025;
14
(9)
:5324-5341
.
(30 September 2025)
Establishment and characterization of two patient-derived cell lines from a patient with gallbladder carcinoma
Translational Cancer Research
2025;
14
(9)
:5342-5352
.
(30 September 2025)
TFAP2A induces cisplatin resistance via BNIP3-mediated mitophagy in non-small cell lung cancer
Translational Cancer Research
2025;
14
(9)
:5353-5369
.
(30 September 2025)
The development and validation of a novel programmed cell death-related signature based on machine learning analysis of 15 programmed cell death patterns for predicting prognosis and therapeutic response in high-grade serous ovarian carcinoma
Translational Cancer Research
2025;
14
(9)
:5370-5394
.
(30 September 2025)
Identification of basement membrane-based prognostic signature and potential therapeutic drugs in hepatocellular carcinoma
Translational Cancer Research
2025;
14
(9)
:5395-5410
.
(30 September 2025)
The prognostic impact of preoperative radiotherapy in stage I rectal cancer: a retrospective cohort study revealing no survival benefit from SEER database analysis
Translational Cancer Research
2025;
14
(9)
:5411-5424
.
(30 September 2025)
FAM83A may serve as a potential prognostic indicator for stomach adenocarcinoma
Translational Cancer Research
2025;
14
(9)
:5425-5440
.
(30 September 2025)
Effect and mechanism of auranofin on extrusion and migration of breast cancer cells
Translational Cancer Research
2025;
14
(9)
:5441-5450
.
(30 September 2025)
Integrating prognosis-related genes with immune-related gene signature for development and validation of a survival stratification model for early-stage colorectal cancer
Translational Cancer Research
2025;
14
(9)
:5451-5464
.
(30 September 2025)
Nomogram for development and validation of a prognosis prediction model for cancer-specific survival in young breast cancer patients with stage I–III based on the Surveillance, Epidemiology, and End Results (SEER) database
Translational Cancer Research
2025;
14
(9)
:5465-5476
.
(30 September 2025)
A novel machine learning-based predictive model for gastric cancer
Translational Cancer Research
2025;
14
(9)
:5477-5489
.
(30 September 2025)
CMTM4 overexpression inhibited tumor growth through regulating the function of myeloid-derived suppressor cells in the cervical cancer microenvironment
Translational Cancer Research
2025;
14
(9)
:5490-5503
.
(30 September 2025)
Computed tomography-based quantification of intra-tumoral heterogeneity for predicting treatment response to concurrent chemoradiotherapy in non-small cell lung cancer: a multicenter retrospective study
Translational Cancer Research
2025;
14
(9)
:5504-5519
.
(30 September 2025)
N6-adenosine methyltransferase METTL4 is a potential prognostic biomarker and associates with cell cycle regulation and immune infiltration in glioma
Translational Cancer Research
2025;
14
(9)
:5520-5533
.
(30 September 2025)
Development of a mitochondrial permeability transition-driven necrosis-linked lncRNA signature for forecasting prognosis and treatment of lung adenocarcinoma
Translational Cancer Research
2025;
14
(9)
:5534-5549
.
(30 September 2025)
The relationship and predictive efficacy of serum lipocalin-2, PDK1, NGALR and lymph node metastasis in postmenopausal endometrial cancer
Translational Cancer Research
2025;
14
(9)
:5550-5558
.
(30 September 2025)
Prognostic factors and overall survival for second primary malignancies in myelodysplastic syndromes: a Cox regression coupled with competing risk model based on Surveillance, Epidemiology, and End Results (SEER) database
Translational Cancer Research
2025;
14
(9)
:5559-5571
.
(30 September 2025)
Immunogenomic classification and nomogram development and validation for colorectal cancer survival prediction based on immune-related genes
Translational Cancer Research
2025;
14
(9)
:5572-5585
.
(30 September 2025)
TFP12 as a key regulator of sentinel lymph node metastasis in breast cancer
Translational Cancer Research
2025;
14
(9)
:5586-5600
.
(30 September 2025)
Demystifying programmed cell death in lung adenocarcinoma: combined prognostic model construction
Translational Cancer Research
2025;
14
(9)
:5601-5620
.
(30 September 2025)
Predictive value of random forest prediction model based on postoperative adjuvant transcatheter arterial chemoembolization therapy for survival of hepatocellular carcinoma patients with microvascular invasion: a retrospective cohort study
Translational Cancer Research
2025;
14
(9)
:5621-5636
.
(30 September 2025)
Efficacy and safety of toripalimab in the treatment of patients with non-small cell lung cancer: a systematic review and meta-analysis
Translational Cancer Research
2025;
14
(9)
:5637-5648
.
(30 September 2025)
MicroRNA-125b inhibits apoptosis and increases gemcitabine resistance by downregulating the expression of BAK1 in pancreatic ductal adenocarcinoma
Translational Cancer Research
2025;
14
(9)
:5649-5663
.
(30 September 2025)
Prognostic difference of single metastasis in different sites of hepatocellular carcinoma: a population-based study
Translational Cancer Research
2025;
14
(9)
:5664-5679
.
(30 September 2025)
Integration analysis of single-cell transcriptome reveals SPP1+ and TFF3+ macrophage subsets contributing to the brain metastasis from lung cancer
Translational Cancer Research
2025;
14
(9)
:5680-5693
.
(30 September 2025)
DTX3 inhibits cell migration, invasion, and epithelial-mesenchymal transition in colorectal cancer through the AKT signaling pathway
Translational Cancer Research
2025;
14
(9)
:5694-5708
.
(30 September 2025)
Factors affecting chemotherapy-induced peripheral neuropathy in patients with breast cancer: a cross-sectional study in China
Translational Cancer Research
2025;
14
(9)
:5709-5719
.
(30 September 2025)
Constructing a chemokine-based model and identifying CCL17 as a core biomarker associated with immune infiltrates in thyroid cancer
Translational Cancer Research
2025;
14
(9)
:5720-5744
.
(30 September 2025)
Pan-cancer evaluation of ABAT as an emerging biomarker and its implication in lung adenocarcinoma
Translational Cancer Research
2025;
14
(9)
:5745-5763
.
(30 September 2025)
Primary signet-ring cell carcinoma of the bile duct: clinical characteristics, survival comparison with cholangiocarcinoma, and SEER-based prognostic nomograms
Translational Cancer Research
2025;
14
(9)
:5764-5776
.
(30 September 2025)
APOA2 mediates immune therapy tolerance in hepatocellular carcinoma by inhibiting the antigen-presenting function of dendritic cells through the PPAR signaling pathway
Translational Cancer Research
2025;
14
(9)
:5777-5791
.
(30 September 2025)
Identifying senescent cells as prognostic biomarkers and therapeutic targets of nasopharyngeal carcinoma by integrated analysis of single-cell and bulk-RNA sequencing data
Translational Cancer Research
2025;
14
(9)
:5792-5811
.
(30 September 2025)
Adagrasib in the treatment of KRASG12C-mutated non-small cell lung cancer: a cost-effectiveness analysis
Translational Cancer Research
2025;
14
(9)
:5812-5822
.
(30 September 2025)
Circular RNA hsa_circ_0006522 correlates with unfavorable prognosis and promotes the proliferative, migrative, and invasive abilities of breast cancer cells
Translational Cancer Research
2025;
14
(9)
:5823-5837
.
(30 September 2025)
Cancer-associated fibroblasts as facilitators in nasopharyngeal carcinoma progression via exosomal MMP13
Translational Cancer Research
2025;
14
(9)
:5838-5852
.
(30 September 2025)
Real-time prognosis prediction with conditional survival analysis for skull base chordoma based on SEER
Translational Cancer Research
2025;
14
(9)
:5853-5862
.
(30 September 2025)
Pancreatic cancer with liver metastasis benefits from chemoradiotherapy compared to chemotherapy alone: a retrospective cohort study from the Surveillance, Epidemiology, and End Results (SEER) database
Translational Cancer Research
2025;
14
(9)
:5863-5872
.
(30 September 2025)
An immune-related miRNA signature predicts the prognosis in nasopharyngeal carcinoma
Translational Cancer Research
2025;
14
(9)
:5873-5883
.
(30 September 2025)
The role of YTHDF1 in the diagnosis and prognosis of lung adenocarcinoma and its inhibitor LY-411575 in the targeted intervention of lung adenocarcinoma growth
Translational Cancer Research
2025;
14
(9)
:5884-5905
.
(30 September 2025)
SNORD93 suppresses colorectal cancer progression by inducing G0/G1 arrest and apoptosis
Translational Cancer Research
2025;
14
(9)
:5906-5918
.
(30 September 2025)
Clinical features as prognostic markers in patients with solid tumors treated with programmed cell death protein 1/programmed cell death-ligand 1 inhibitors: a retrospective cohort study
Translational Cancer Research
2025;
14
(9)
:5919-5932
.
(30 September 2025)
Development and validation of a lipid metabolism-related prognostic model for gastric adenocarcinoma
Translational Cancer Research
2025;
14
(9)
:5933-5951
.
(30 September 2025)
Pathways linking benefit finding, fear of cancer recurrence, and family support to fertility concerns in women of reproductive age with malignant tumors: a cross-sectional study
Translational Cancer Research
2025;
14
(9)
:5952-5964
.
(30 September 2025)
Association between the age-adjusted visceral adiposity index (AVAI) and gynecologic malignancies: a cross-sectional study based on NHANES data
Translational Cancer Research
2025;
14
(9)
:5965-5978
.
(30 September 2025)
Screening of PANoptosis regulator-associated long noncoding RNAs and construction of a survival prognostic model in cutaneous melanoma
Translational Cancer Research
2025;
14
(9)
:5979-5998
.
(30 September 2025)
METRN modulates immune escape via CD8+ T cells in breast cancer progression through IL-6 signaling pathway
Translational Cancer Research
2025;
14
(9)
:5999-6021
.
(30 September 2025)
Review Article
Pathophysiology and perioperative dystrophy of esophagus cancer: association with malnutrition
Translational Cancer Research
2025;
14
(9)
:6022-6040
.
(30 September 2025)
The mechanism and research progress of PD-1/PD-L1 on immune escape of lung cancer
Translational Cancer Research
2025;
14
(9)
:6041-6051
.
(30 September 2025)
PARP-1 in tumor complicated with depression—possible role and therapeutic perspective: a narrative review
Translational Cancer Research
2025;
14
(9)
:6052-6064
.
(30 September 2025)
Recent advances in development of CDK7 inhibitors and their clinical trials: a narrative review
Translational Cancer Research
2025;
14
(9)
:6065-6078
.
(30 September 2025)
A systematic review of multiparametric magnetic resonance imaging radiomics in the prediction of brain invasion in meningioma
Translational Cancer Research
2025;
14
(9)
:6079-6091
.
(30 September 2025)
Multi-gene expression assays in breast cancer: a literature review
Translational Cancer Research
2025;
14
(9)
:6092-6101
.
(30 September 2025)
Prospective proteomics for discovering biomarkers in lung adenocarcinoma: a literature review
Translational Cancer Research
2025;
14
(9)
:6102-6117
.
(30 September 2025)
Case Report
An innovative surgical approach using the hepatic falciform ligament to repair bronchobiliary fistula after radiofrequency ablation: a case report
Translational Cancer Research
2025;
14
(9)
:6118-6126
.
(30 September 2025)
Letter to the Editor
Response to the letter regarding ‘Construction and validation of a nomogram prediction model for predicting the risk of chemotherapy-induced myelosuppression after chemotherapy in patients with triple-negative breast cancer’
Translational Cancer Research
2025;
14
(9)
:6127-6129
.
(30 September 2025)
Incorporating host genetics and inflammation in myelosuppression risk prediction for triple-negative breast cancer
Translational Cancer Research
2025;
14
(9)
:6130-6131
.
(30 September 2025)
Erratum
Erratum: Therapeutic potential of anti-miR29a in breast cancer patients with type 2 diabetes: an in vitro and xenograft mouse-model study
Translational Cancer Research
2025;
14
(9)
:6132-6133
.
(30 September 2025)
Erratum: Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells
Translational Cancer Research
2025;
14
(9)
:6134-6135
.
(30 September 2025)
